Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 KBI Biopharma, Argonaut Partner on Drug Product & Mfg. Services | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

KBI Biopharma, Argonaut Partner on Drug Product & Mfg. Services

Combines KBI’s drug development and biologics manufacturing services with Argonaut’s expertise in sterile fill-finish.

By: Anthony Vecchione

KBI Biopharma, Inc., a JSR Life Sciences company and CDMO, and Argonaut Manufacturing Services, Inc., a CMO for biopharmaceutical and diagnostics, entered into a strategic alliance to offer end-to-end drug substance and drug product manufacturing services. The arrangement integrates drug substance and drug product manufacturing by combining KBI’s drug development and biologics manufacturing services with Argonaut’s expertise in sterile fill-finish.

“At KBI Biopharma, we have always been committed to delivering innovative solutions that accelerate the development and manufacturing of life-saving therapeutics,” said J.D. Mowery, President, and CEO of KBI Biopharma. “Our state-of-the-art facilities and world-class team have consistently pushed the boundaries of what is possible in biopharmaceutical development.”

Wayne Woodard, founder, and CEO of Argonaut said, “We believe this strategic alliance resolves a key issue for biopharmaceutical organizations as it greatly improves the alignment and integration between two complex and critical aspects of drug development and manufacturing. Biopharmaceutical companies will benefit from an integrated solution that is faster, more flexible, and leverages the unique expertise of our two organizations. Argonaut’s fill-finish capabilities are scalable from first-in-human clinical material for rare diseases through commercial batches of approved products.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics